Since 1995, the American Academy of Neurology has provided guidelines for brain death determination, but nationwide adherence to these guidelines has been incomplete.
AMA J Ethics. 2020;22(12):E1027-1032. doi:
10.1001/amajethics.2020.1027.
Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves.
Being marked as an “other” outside of the circle of human concern expresses tension between principles of liberty and equality and exacerbates health inequity.
AMA J Ethics. 2021;23(2):E166-174. doi:
10.1001/amajethics.2021.166.
Dr Mollie V. Willliams joins Ethics Talk to discuss her article, coauthored with Dr Olaitan Ajisafe: “How Should Exposure Risk to Tactical Personnel Be Balanced Against Clinical and Ethical Rescue Demand?”
This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing.
AMA J Ethics. 2021;23(6):E471-479. doi:
10.1001/amajethics.2021.471.